May 2026 Update: In May 2026, The Lancet published a landmark consensus paper renaming PCOS to PMOS, polyendocrine metabolic ovarian syndrome. The new name reflects what Nico teaches in this episode: this is a metabolic and endocrine condition, not an ovarian one. The ovaries are downstream. Read our full breakdown of the rename and what it means clinically: PCOS Just Got a New Name
In this solo episode of the Nico Misleh Podcast, host Nico Misleh dives into the origins of PCOS and why the common view of the condition misses important early drivers. Nico speaks directly to clinicians and curious listeners alike, arguing that polycystic ovarian syndrome is more than a late-stage metabolic disease. He explains how stress, hormone imbalance, gut health, and environmental toxins often start the cascade long before insulin resistance appears.
Why The Name PCOS Can Be Misleading
Nico points out that the name polycystic ovarian syndrome suggests that visible ovarian cysts are required for diagnosis. In practice, that is not true. He explains that PCOS is a syndrome with many contributing factors and that the hallmarks often develop years before classic signs like hirsutism or obesity. Clinicians who expect later-stage symptoms may miss early, treatable disease. In May 2026, The Lancet formally acknowledged this by renaming PCOS to PMOS, polyendocrine metabolic ovarian syndrome, placing metabolic and endocrine dysfunction at the center of the condition rather than the ovaries.
Stress, Cortisol, and the Real Root Cause of PCOS (Now PMOS)
At the core of Nico’s message is the idea that PCOS (now renamed PMOS, polyendocrine metabolic ovarian syndrome) often begins with hormone disruption driven by chronic stress. Chronically high cortisol and elevated adrenaline can damage the gut lining. This can allow bacterial endotoxins such as lipopolysaccharides to enter circulation, driving systemic inflammation.
That inflammation then shifts estrogen and immune signaling in ways that feed back into the stress response. Estrogen can increase histamine and inflammation, which in turn can further raise cortisol. This creates a vicious cycle that harms metabolic function long before insulin resistance becomes obvious. This is the cascade that the HRT University Master Course covers in depth across Module 1 (metabolic foundations) and Module 4 (advanced female endocrinology).
Progesterone and Thyroid: Two Underappreciated Protectors
Nico emphasizes that progesterone and thyroid hormones are powerful anti-stress, pro-metabolic actors. Progesterone helps reduce inflammation, support immune balance, and protect the gut lining. Thyroid hormones are essential for cellular energy production and gut motility. When both are low, or when tissues develop resistance to progesterone, the body becomes less able to respond to stress and heal.
According to Nico, this deficiency in progesterone and thyroid function often precedes and contributes to the insulin resistance associated with later-stage PCOS. He argues that treating these early hormonal deficits can prevent progression and improve quality of life. The 2026 Lancet rename to PMOS (polyendocrine metabolic ovarian syndrome) now places these hormonal and metabolic drivers at the center of the condition’s definition.
Gut Permeability, Endotoxins, and Inflammation
Nico explains how chronic stress can weaken the gut barrier and allow bacterial products like LPS to trigger systemic inflammation. These endotoxins stimulate cytokines such as interleukin 6 and encourage an estrogen-dominant state. That state further stimulates cortisol and destabilizes blood sugar control. Understanding this gut-to-hormone connection is central to Nico’s clinical approach and is covered in detail in Module 4 of the Master Course.
Treatment Thoughts: Hormones, Nutrients, and Avoiding Masking Strategies
Nico advocates for a thoughtful, early use of bioidentical hormones (particularly progesterone and thyroid therapy) alongside lifestyle and nutritional interventions. He makes several practical points:
- Not every patient with PCOS/PMOS needs metformin or GLP-1 agonists right away. Those tools are important for late-stage, insulin-resistant patients, but may not be the first step for younger or lean patients.
- Oral contraceptives can mask PCOS (now PMOS) by shutting down endogenous hormones. They may relieve symptoms but do not address root causes and can worsen metabolic risk over time.
- Replacing deficient hormones with bioidentical progesterone and correcting thyroid dysfunction can improve mood, sleep, energy, and metabolic resilience.
- Specific nutrients show utility in PCOS care. Myo-inositol, vitamin E, thiamine (B1), berberine, and other targeted supplements can support metabolism and counteract environmental toxin effects.
- Addressing diet, removing processed foods, reducing inflammatory fats, and minimizing exposures to endocrine-disrupting chemicals remain essential.
These interventions are covered across the HRT University Master Course, with the metabolic framework in Module 1, female hormone therapy in Module 3, the advanced PCOS and endometriosis deep dive in Module 4, and thyroid optimization in Module 5.
Spotting PCOS (Now PMOS) Earlier
Nico urges clinicians to catch PCOS, now known as PMOS, before the more dramatic symptoms arrive. Early flags might include low progesterone symptoms, anxiety, insomnia, irregular cycles, and subtle increases in fasting insulin or free androgens that remain within reference ranges but are high for the patient. He stresses the need to listen to patients who say they are trying and still struggling, rather than dismissing them as simply having poor lifestyle habits. The 2026 rename to PMOS reinforces why early detection matters: if the condition is metabolic and endocrine from the start, waiting for insulin resistance means you have already missed the window for earlier intervention.
Environmental Context and Generational Trends
PCOS and male hypogonadism appear to be more common now than decades ago. Nico links this trend to rising exposure to xenoestrogens and endocrine-disrupting chemicals like phthalates and PFAS. These exposures can begin in utero and influence hormonal development across generations. He calls for compassion for patients who were exposed before birth and for clinical strategies that do not simply blame the patient.
Clinical Attitude and Appropriate Therapy
Nico contrasts symptom-masking approaches such as benzodiazepines or routine birth control with targeted hormone replacement that addresses root causes. He frames the objective of therapy as improving both symptoms and long-term health. In his view, the most appropriate therapy for PCOS/PMOS is the one that resolves symptoms while improving overall healthspan and quality of life. Bioidentical progesterone and thyroid optimization sit at the center of that approach, which is exactly what the PMOS rename now points toward.
Key Takeaways
- The root cause of PCOS begins with stress-driven hormone disruption long before insulin resistance appears.
- Progesterone and thyroid hormones are vital early defenders and are often underused in treatment.
- Gut permeability and bacterial endotoxins can drive systemic inflammation and estrogen dominance.
- Oral contraceptives can mask but not cure PCOS; bioidentical hormone therapy and nutrients can treat root causes.
- Early detection and a holistic approach yield better long-term outcomes than waiting for late-stage metabolic disease.
- In May 2026, The Lancet renamed PCOS to PMOS (polyendocrine metabolic ovarian syndrome), formally recognizing the metabolic and endocrine framework this episode describes.
How This Connects to the PMOS Rename
In May 2026, a Lancet consensus paper involving 22,000 clinicians and patients across 11 years officially renamed PCOS to PMOS: polyendocrine metabolic ovarian syndrome. The new name reflects the clinical reality Nico describes in this episode. PCOS was never primarily an ovarian condition. It is metabolic. It is endocrine. The ovaries are downstream of cortisol dysregulation, gut permeability, endotoxin-driven inflammation, and progesterone and thyroid insufficiency. The metabolic framework behind PMOS is covered in depth across Module 1 (metabolic foundations), Module 4 (advanced female), and Module 5 (thyroid optimization) of the HRT University Master Course. Read the full breakdown of what the PCOS to PMOS rename means clinically.
FAQ
Q: What is PMOS and how does it relate to PCOS?
A: In May 2026, The Lancet published a consensus paper renaming PCOS to PMOS, polyendocrine metabolic ovarian syndrome. The rename reflects 11 years of research involving 22,000 clinicians and patients. The new name acknowledges that this condition is driven by metabolic and endocrine dysfunction, not by the ovaries. The ovaries are downstream. This is the same framework Nico teaches in this episode and across the HRT University Master Course: cortisol dysregulation, endotoxin-driven inflammation, and progesterone and thyroid insufficiency precede and drive the insulin resistance traditionally associated with PCOS. Full adoption in international guidelines is projected for 2028. Read the full clinical breakdown of the rename.
Q: Should every patient with suspected PCOS start metformin?
A: Not necessarily. Metformin and GLP1 agonists are powerful tools for patients with clear insulin resistance and obesity. For younger, lean patients with early hormone imbalance, addressing progesterone and thyroid often comes first.
Q: Are birth control pills a good long-term solution?
A: Birth control can relieve symptoms, but it often masks the underlying dysfunction. Over the years, it can worsen metabolic risk because it suppresses endogenous hormones rather than restoring balance.
Q: What tests should clinicians order early?
A: Basic hormone panels, including progesterone, free testosterone, DHEA, fasting insulin, and thyroid function, can be helpful. Look for trends and values that are high relative to the patient, even if they fall inside reference ranges.
Q: Which nutrients are helpful for PCOS?
A: Myo-inositol, vitamin E, thiamine (B1), berberine, and targeted antioxidants can support metabolism and counteract some toxicant effects. Treatment should be individualized.
Ready To Learn More?
The metabolic framework behind the PCOS to PMOS rename is exactly what Nico teaches across the HRT University Master Course. Module 1 builds the metabolic foundation. Module 4 takes you deep into PCOS, endometriosis, and the endotoxin connection. Module 5 covers thyroid optimization. If this episode resonated, the course is where the full clinical reasoning lives.
Join Nico’s free daily newsletter for ongoing insights, clinical pearls, and real-world strategies delivered Monday through Friday.
